Former FDA commissioner Dr. Scott Gottlieb joins 'Power Lunch' to discuss Eli Lilly's highly anticipated weight-loss drug Zepbound, the demand and supply equation in the weight-loss drug space, and more...Former FDA commissioner: Expect more competition in Eli Lilly and Novo Nordisk's weight-loss drugs 0915938fa